Live register
Drugs in short supply
1,181 products are currently reported in shortage to the FDA. Each row links to the manufacturer’s entry, so you can see what else they make and where. Most recently updated first; page 4 of 5. What changed this week / How many companies make each one.
| Drug | Manufacturer | Presentation | Availability | Updated |
|---|---|---|---|---|
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | Available | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | Unavailable | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Unavailable | 15 Sept 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) | Available | 15 Sept 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) | Available | 15 Sept 26 |
| Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) | Available | 15 Sept 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) | Available | 15 Sept 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) | Available | 15 Sept 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) | Available | 15 Sept 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) | Available | 15 Sept 26 |
| Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Unavailable | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Unavailable | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Unavailable | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Unavailable | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Available | 15 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Available | 15 Sept 26 |
| Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Unavailable | 15 Sept 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Available | 15 Sept 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Available | 15 Sept 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Available | 15 Sept 26 |
| Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Available | 15 Sept 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) | Available | 15 Sept 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) | Available | 15 Sept 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) | Unavailable | 15 Sept 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) | Unavailable | 15 Sept 26 |
| Furosemide Injection | Accord Healthcare Inc. | Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) | Unavailable | 15 Sept 26 |
| Furosemide Injection | Fresenius Kabi USA, LLC | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) | Available | 15 Sept 26 |
| Heparin Sodium Injection | Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Available | 15 Sept 26 |
| Heparin Sodium Injection | Fresenius Kabi USA, LLC | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Unavailable | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Available | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Available | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Available | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Available | 15 Sept 26 |
| Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Unavailable | 15 Sept 26 |
| Ifosfamide Injection | Fresenius Kabi USA, LLC | Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) | Limited Availability | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Available | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Unavailable | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Unavailable | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Unavailable | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Unavailable | 15 Sept 26 |
| Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Unavailable | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Available | 15 Sept 26 |
| Lidocaine Hydrochloride Injection | Anthea Pharma | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Takeda Pharmaceuticals USA Inc. | Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Available | 15 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Takeda Pharmaceuticals USA Inc. | Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Available | 15 Sept 26 |
| Lorazepam Injection | Fresenius Kabi USA, LLC | Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Unavailable | 15 Sept 26 |
| Methotrexate Sodium Injection | Fresenius Kabi USA, LLC | Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50) | Available | 15 Sept 26 |
| Methotrexate Sodium Injection | Accord Healthcare Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) | Unavailable | 15 Sept 26 |
| Methotrexate Sodium Injection | Fresenius Kabi USA, LLC | Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10) | Available | 15 Sept 26 |
| Methotrexate Sodium Injection | Accord Healthcare Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) | Unavailable | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Available | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Available | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Unavailable | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Available | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Unavailable | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Unavailable | 15 Sept 26 |
| Midazolam Hydrochloride Injection | Fresenius Kabi USA, LLC | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Unavailable | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Unavailable | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Unavailable | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Unavailable | 15 Sept 26 |
| Morphine Sulfate Injection | Piramal Critical Care Inc. | Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) | Available | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Unavailable | 15 Sept 26 |
| Morphine Sulfate Injection | Piramal Critical Care Inc. | Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) | Available | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Available | 15 Sept 26 |
| Morphine Sulfate Injection | Fresenius Kabi USA, LLC | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Unavailable | 15 Sept 26 |
| Penicillin G Benzathine Injection | Laboratorios Atral | Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Available | 15 Sept 26 |
| Propranolol Hydrochloride Injection | Fresenius Kabi USA, LLC | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Available | 15 Sept 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Available | 15 Sept 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Available | 15 Sept 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Available | 15 Sept 26 |
| Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Available | 15 Sept 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Available | 15 Sept 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Available | 15 Sept 26 |
| Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Available | 15 Sept 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Unavailable | 15 Sept 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Available | 15 Sept 26 |
| Remifentanil Hydrochloride Injection | Fresenius Kabi USA, LLC | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Available | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 150 mg (NDC 42806-801-01) | Unavailable | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-60) | Available | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-05) | Unavailable | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 150 mg (NDC 42806-801-30) | Available | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-30) | Unavailable | 15 Sept 26 |
| Rifampin Capsule | Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-01) | Unavailable | 15 Sept 26 |
| Rifampin Injection | Fresenius Kabi USA, LLC | Rifampin, Injection, 600 mg (NDC 63323-351-20) | Limited Availability | 15 Sept 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Available | 15 Sept 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Unavailable | 15 Sept 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Unavailable | 15 Sept 26 |
| Rocuronium Bromide Injection | Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Limited Availability | 15 Sept 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Available | 15 Sept 26 |
| Rocuronium Bromide Injection | Fresenius Kabi USA, LLC | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Available | 15 Sept 26 |
| Rocuronium Bromide Injection | Piramal Critical Care Inc. | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Unavailable | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Available | 15 Sept 26 |
| Ropivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Unavailable | 15 Sept 26 |
| Sodium Acetate Injection | Fresenius Kabi USA, LLC | Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Available | 15 Sept 26 |
| Sodium Bicarbonate Injection | Fresenius Kabi USA, LLC | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) | Available | 15 Sept 26 |
| Sodium Bicarbonate Injection | Fresenius Kabi USA, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) | Available | 15 Sept 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76) | Available | 15 Sept 26 |
| Sterile Water Injection | Medefil, Inc. | Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30) | Available | 15 Sept 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20) | Available | 15 Sept 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50) | Available | 15 Sept 26 |
| Sterile Water Injection | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10) | Unavailable | 15 Sept 26 |
| Streptozocin Powder, For Solution | Teva Pharmaceuticals USA, Inc. | Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) | Unavailable | 15 Sept 26 |
| Triamcinolone Hexacetonide Injection | Medexus | Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Available | 15 Sept 26 |
| Valproate Sodium Injection | Fresenius Kabi USA, LLC | Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Available | 15 Sept 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Available | 11 Sept 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Available | 11 Sept 26 |
| Atropine Sulfate Injection | Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) | Available | 11 Sept 26 |
| Bupivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10) | Available | 11 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Somerset Therapeutics, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) | Available | 11 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Somerset Therapeutics, LLC | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | Available | 11 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Somerset Therapeutics, LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04) | Available | 11 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Somerset Therapeutics, LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04) | Available | 11 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-0025-10) | Available | 11 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-0151-10) | Available | 11 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-1100-10) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Available | 11 Sept 26 |
| Ropivacaine Hydrochloride Injection | Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Available | 11 Sept 26 |
| Sodium Acetate Injection | Somerset Therapeutics, LLC | Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) | Available | 11 Sept 26 |
| Sodium Acetate Injection | Somerset Therapeutics, LLC | Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) | Available | 11 Sept 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Unavailable | 09 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10) | Available | 09 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10) | Available | 09 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30) | Available | 09 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29) | Available | 09 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10) | Unavailable | 09 Sept 26 |
| Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34) | Unavailable | 09 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32) | Available | 09 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32) | Available | 09 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32) | Available | 09 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22) | Available | 09 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22) | Available | 09 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Unavailable | 09 Sept 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59) | Available | 09 Sept 26 |
| Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03) | Available | 09 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-25) | Unavailable | 09 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-25) | Unavailable | 09 Sept 26 |
| Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-25) | Unavailable | 09 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34) | Unavailable | 09 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Available | 09 Sept 26 |
| Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34) | Unavailable | 09 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01) | Unavailable | 09 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30) | Unavailable | 09 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01) | Unavailable | 09 Sept 26 |
| Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Demerol, Injection, 100 mg/1 mL (NDC 0409-1180-69) | Unavailable | 09 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01) | Unavailable | 09 Sept 26 |
| Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05) | Unavailable | 09 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14) | Unavailable | 09 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14) | Unavailable | 09 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14) | Unavailable | 09 Sept 26 |
| Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14) | Unavailable | 09 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) | Available | 08 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) | Available | 08 Sept 26 |
| Ifosfamide Injection | SteriMax, Inc. | Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02) | Available | 08 Sept 26 |
| Bupivacaine Hydrochloride Injection | ONESOURCE SPECIALTY PTE LTD | Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10) | Available | 05 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Available | 02 Sept 26 |
| Clonazepam Tablet | Prinston Pharmaceutical, Inc. | Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Available | 02 Sept 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65) | Available | 02 Sept 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65) | Available | 02 Sept 26 |
| Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65) | Available | 02 Sept 26 |
For manufacturers
A shortage is a sourcing event.
Every product on this list is a molecule somebody urgently needs another source for. If you hold registered capacity for any of them, list it and we will route matching requests to you.
Provenance
Source: FDA drug shortage database via openFDA, refreshed daily. Note that the openFDA feed carries no reason-for-shortage field, so availability and therapeutic category are shown instead of a cause. Shortage status changes between refreshes; check the FDA database directly before acting on it clinically. This site is not affiliated with the FDA. Need shortage exposure joined to every NDC and manufacturer as a file? See the dataset.